Literature DB >> 19471625

Emergencies associated with pregnancy and delivery: peripartum hemorrhage.

Franz Kainer, Uwe Hasbargen.   

Abstract

INTRODUCTION: Peripartum hemorrhage is one of the leading causes of maternal death worldwide (25%).
METHODS: Selective literature review, including international guidelines, for assessment of the causes and optimal management of this condition.
RESULTS: The major causes of hemorrhage are uterine atony, placenta previa, and abruptio placentae. The diagnosis of hemorrhage is suspected from its clinical manifestations and confirmed by ultrasonography. In placenta previa, the placenta is implanted in the lower uterine segment and may cover the internal cervical os. Placenta previa is more common in older and multiparous mothers, as well as in mothers who have previously undergone a cesarean section. Placental abruption is defined as separation of the placenta from the uterine wall before delivery of the infant. The risk factors for this condition include preeclampsia, advanced maternal age, and trauma. When it presents with manifestations of acute blood loss, premature abruption placentae must be diagnosed rapidly and treated without delay to save the life of the mother and child. A rare, but highly lethal, cause of bleeding is amniotic fluid embolism, which manifests itself with sudden and unexplained peripartum respiratory distress and cardiovascular collapse. Amniotic fluid embolism is associated with high fetal and maternal mortality (20% and 60% to 80%, respectively) even when it is optimally treated. DISCUSSION: Peripartum hemorrhage is an important source of maternal and fetal morbidity and mortality. The prognosis for both mother and child can be markedly improved if the risk factors for hemorrhage are recognized and the problem is treated rapidly and appropriately when it arises.

Entities:  

Keywords:  amniotic fluid embolism; maternal mortality; placenta previa; preterm abruption of placenta; third-trimester hemorrhage; uterine atony

Year:  2008        PMID: 19471625      PMCID: PMC2680565          DOI: 10.3238/arztebl.2008.0629

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  39 in total

1.  Clot observation test for clinical diagnosis of clotting defects.

Authors:  M F POE
Journal:  Anesthesiology       Date:  1959 Nov-Dec       Impact factor: 7.892

Review 2.  Maternal collapse.

Authors:  James Clarke; Muhammad Butt
Journal:  Curr Opin Obstet Gynecol       Date:  2005-04       Impact factor: 1.927

3.  The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported.

Authors:  C B-Lynch; A Coker; A H Lawal; J Abu; M J Cowen
Journal:  Br J Obstet Gynaecol       Date:  1997-03

4.  ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

5.  Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section.

Authors:  J S Thomas; S H Koh; G M Cooper
Journal:  Br J Anaesth       Date:  2006-12-02       Impact factor: 9.166

6.  Oral misoprostol for third stage of labor: a randomized placebo-controlled trial.

Authors:  D V Surbek; P M Fehr; I Hösli; W Holzgreve
Journal:  Obstet Gynecol       Date:  1999-08       Impact factor: 7.661

7.  Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV.

Authors:  W Henrich; I Fuchs; T Ehrenstein; S Kjos; A Schmider; J W Dudenhausen
Journal:  Ultrasound Obstet Gynecol       Date:  2002-07       Impact factor: 7.299

8.  Uterine artery embolization in the treatment and prevention of postpartum hemorrhage.

Authors:  E Soncini; A Pelicelli; P Larini; C Marcato; D Monaco; A Grignaffini
Journal:  Int J Gynaecol Obstet       Date:  2007-02-06       Impact factor: 3.561

9.  [Pathophysiological and therapeutic aspects of amniotic fluid embolism (anaphylactoid syndrome of pregnancy): case report with lethal outcome and overview].

Authors:  M Kretzschmar; D-M Zahm; K Remmler; L Pfeiffer; L Victor; W Schirmeister
Journal:  Anaesthesist       Date:  2003-05       Impact factor: 1.041

10.  Investigation of an increase in postpartum haemorrhage in Canada.

Authors:  K S Joseph; J Rouleau; M S Kramer; D C Young; R M Liston; T F Baskett
Journal:  BJOG       Date:  2007-06       Impact factor: 6.531

View more
  7 in total

1.  Cardiovascular side effects.

Authors:  Christiane Goeters; H van Aken
Journal:  Dtsch Arztebl Int       Date:  2009-02-13       Impact factor: 5.594

2.  Different Products.

Authors:  Norbert Ostendorf
Journal:  Dtsch Arztebl Int       Date:  2009-02-13       Impact factor: 5.594

Review 3.  [Anesthesiological management of Caesarean sections : nationwide survey in Germany].

Authors:  H E Marcus; A Behrend; R Schier; O Dagtekin; P Teschendorf; B W Böttiger; F Spöhr
Journal:  Anaesthesist       Date:  2011-08-12       Impact factor: 1.041

4.  Pr-AKI: Acute Kidney Injury in Pregnancy - Etiology, Diagnostic Workup, Management.

Authors:  Florian G Scurt; Ronnie Morgenroth; Katrin Bose; Peter R Mertens; Christos Chatzikyrkou
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-03-03       Impact factor: 2.915

5.  Effect of pregnancy and nitric oxide on the myogenic vasodilation of posterior cerebral arteries and the lower limit of cerebral blood flow autoregulation.

Authors:  Abbie C Chapman; Marilyn J Cipolla; Siu-Lung Chan
Journal:  Reprod Sci       Date:  2013-02-18       Impact factor: 3.060

6.  Major Placenta Previa: Rate, Maternal and Neonatal Outcomes Experience at a Tertiary Maternity Hospital, Sohag, Egypt: A Prospective Study.

Authors:  Salah Roshdy Ahmed; Abdusaeed Aitallah; Hazem M Abdelghafar; Mohamed Alkhatim Alsammani
Journal:  J Clin Diagn Res       Date:  2015-11-01

7.  Prevalence and Fetomaternal Outcome of Placenta Previa at Salmaniya Medical Complex, Bahrain.

Authors:  Fatema Alhubaishi; Naeema Mahmood
Journal:  Cureus       Date:  2022-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.